Cabot Corporation
CBT · NYSE
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.03 | -1.21 | 0.07 | -1.10 |
| FCF Yield | 9.57% | 7.43% | 9.17% | -3.09% |
| EV / EBITDA | 6.24 | 9.18 | 7.22 | 9.15 |
| Quality | ||||
| ROIC | 26.62% | 16.13% | 18.84% | 9.88% |
| Gross Margin | 25.32% | 24.04% | 21.34% | 20.48% |
| Cash Conversion Ratio | 1.77 | 1.63 | 1.23 | 0.41 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.88% | -2.59% | 4.86% | 18.24% |
| Free Cash Flow Growth | -13.30% | 28.49% | 416.22% | -279.03% |
| Safety | ||||
| Net Debt / EBITDA | 1.10 | 1.20 | 1.64 | 2.46 |
| Interest Coverage | 8.17 | 7.58 | 5.84 | 6.95 |
| Efficiency | ||||
| Inventory Turnover | 5.50 | 5.50 | 5.29 | 5.17 |
| Cash Conversion Cycle | 47.01 | 52.07 | 81.88 | 84.53 |